CUTA
gene geneOn this page
Summary
CUTA (cutA divalent cation tolerance homolog, HGNC:21101) is a protein-coding gene on chromosome 6p21.32, encoding Protein CutA (O60888). May form part of a complex of membrane proteins attached to acetylcholinesterase (AChE).
Enables enzyme binding activity. Involved in protein localization. Located in membrane and mitochondrion.
Source: NCBI Gene 51596 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 46 total
- Druggable target: yes
- MANE Select transcript:
NM_001014840
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21101 |
| Approved symbol | CUTA |
| Name | cutA divalent cation tolerance homolog |
| Location | 6p21.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000112514 |
| Ensembl biotype | protein_coding |
| OMIM | 616953 |
| Entrez | 51596 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 9 protein_coding, 4 retained_intron, 2 nonsense_mediated_decay
ENST00000374484, ENST00000374496, ENST00000374500, ENST00000440279, ENST00000462802, ENST00000465956, ENST00000479249, ENST00000482684, ENST00000487637, ENST00000488034, ENST00000488478, ENST00000492510, ENST00000494751, ENST00000607266, ENST00000879000
RefSeq mRNA: 5 — MANE Select: NM_001014840
NM_001014433, NM_001014837, NM_001014838, NM_001014840, NM_015921
CCDS: CCDS34433, CCDS4779
Canonical transcript exons
ENST00000440930 — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 99.40.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 207.7535 / max 754.7523, expressed in 1828 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 73161 | 84.1255 | 1825 |
| 73164 | 51.9452 | 1824 |
| 73165 | 41.8743 | 1818 |
| 73162 | 21.1667 | 1781 |
| 73163 | 7.2983 | 1734 |
| 73159 | 0.9390 | 522 |
| 73160 | 0.4045 | 166 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pituitary gland | UBERON:0000007 | 99.40 | gold quality |
| adenohypophysis | UBERON:0002196 | 99.40 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 99.09 | gold quality |
| right adrenal gland | UBERON:0001233 | 99.08 | gold quality |
| left adrenal gland | UBERON:0001234 | 99.08 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 99.08 | gold quality |
| putamen | UBERON:0001874 | 98.93 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.90 | gold quality |
| nucleus accumbens | UBERON:0001882 | 98.90 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 98.89 | gold quality |
| caudate nucleus | UBERON:0001873 | 98.84 | gold quality |
| stromal cell of endometrium | CL:0002255 | 98.81 | gold quality |
| thyroid gland | UBERON:0002046 | 98.78 | gold quality |
| right uterine tube | UBERON:0001302 | 98.75 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 98.73 | gold quality |
| fundus of stomach | UBERON:0001160 | 98.71 | gold quality |
| prefrontal cortex | UBERON:0000451 | 98.70 | gold quality |
| endocervix | UBERON:0000458 | 98.70 | gold quality |
| hypothalamus | UBERON:0001898 | 98.70 | gold quality |
| primary visual cortex | UBERON:0002436 | 98.70 | gold quality |
| substantia nigra | UBERON:0002038 | 98.67 | gold quality |
| left ovary | UBERON:0002119 | 98.67 | gold quality |
| right frontal lobe | UBERON:0002810 | 98.67 | gold quality |
| brain | UBERON:0000955 | 98.64 | gold quality |
| cortex of kidney | UBERON:0001225 | 98.64 | gold quality |
| body of stomach | UBERON:0001161 | 98.63 | gold quality |
| Ammon’s horn | UBERON:0001954 | 98.63 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 98.63 | gold quality |
| frontal cortex | UBERON:0001870 | 98.62 | gold quality |
| amygdala | UBERON:0001876 | 98.62 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6819 | yes | 562.88 |
| E-GEOD-81547 | no | 10.56 |
| E-HCAD-31 | no | 2.20 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
4 targeting CUTA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-186-3P | 99.51 | 66.24 | 1685 |
| HSA-MIR-619-3P | 98.38 | 65.58 | 693 |
| HSA-MIR-6765-3P | 97.83 | 64.59 | 1165 |
| HSA-MIR-483-5P | 93.53 | 65.81 | 111 |
Literature-anchored findings (GeneRIF, showing 6)
- Fluorescence in situ hybridization localizes the gene to chromosome 6p21.32-p21.2. (PMID:10800960)
- expression profile of CUTA gene in tissues was examined & revealed CUTA gene was constitutively expressed in the 18 tissues tested; CUTA isoform2 was mainly located in mitochondria as a new potential mitochondrial protein (PMID:17924204)
- H component of CUTA as a novel BACE1-interacting protein that mediates the intracellular trafficking of BACE1 and the processing of APP to Abeta (PMID:22351782)
- Human CutA1 exhibits remarkably high thermodynamic stability at body temperature should be important for its protein catabolism in the human cells. (PMID:25344844)
- It mediates APP processing and Abeta generation. (PMID:25557959)
- Epigenome-wide Association Study Shows Differential DNA Methylation of MDC1, KLF9, and CUTA in Autoimmune Thyroid Disease. (PMID:37962983)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cuta | ENSMUSG00000024194 |
| rattus_norvegicus | Cuta | ENSRNOG00000000481 |
| drosophila_melanogaster | CG11590 | FBGN0030545 |
| caenorhabditis_elegans | WBGENE00009443 |
Protein
Protein identifiers
Protein CutA — O60888 (reviewed: O60888)
Alternative names: Acetylcholinesterase-associated protein, Brain acetylcholinesterase putative membrane anchor
All UniProt accessions (5): O60888, C9IZG4, C9IZQ5, F2Z2Q5, H0YDR4
UniProt curated annotations — full annotation on UniProt →
Function. May form part of a complex of membrane proteins attached to acetylcholinesterase (AChE).
Subunit / interactions. Homotrimer.
Tissue specificity. Ubiquitous. Widely expressed in brain.
Post-translational modifications. O-glycosylated.
Similarity. Belongs to the CutA family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O60888-1 | B | yes |
| O60888-2 | A | |
| O60888-3 | C |
RefSeq proteins (5): NP_001014433, NP_001014837, NP_001014838, NP_001014840, NP_057005 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004323 | Ion_tolerance_CutA | Family |
| IPR011322 | N-reg_PII-like_a/b | Homologous_superfamily |
| IPR015867 | N-reg_PII/ATP_PRibTrfase_C | Homologous_superfamily |
Pfam: PF03091
UniProt features (14 total): strand 5, helix 4, splice variant 2, signal peptide 1, chain 1, region of interest 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2ZFH | X-RAY DIFFRACTION | 2.05 |
| 1XK8 | X-RAY DIFFRACTION | 2.7 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60888-F1 | 80.16 | 0.63 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 176 (showing top):
CGGAARNGGCNG_UNKNOWN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, TGACCTY_ERR1_Q2, CAGCTG_AP4_Q5, AACWWCAANK_UNKNOWN, COUP_01, GOBP_RESPONSE_TO_METAL_ION, PATIL_LIVER_CANCER, TCF4_Q5, ATF1_Q6, USF_01, TCF11_01, HNF4_DR1_Q3, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, HNF4_01
GO Biological Process (2): intracellular protein localization (GO:0008104), response to metal ion (GO:0010038)
GO Molecular Function (3): copper ion binding (GO:0005507), enzyme binding (GO:0019899), protein binding (GO:0005515)
GO Cellular Component (3): mitochondrion (GO:0005739), membrane (GO:0016020), extracellular exosome (GO:0070062)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| macromolecule localization | 1 |
| response to chemical | 1 |
| transition metal ion binding | 1 |
| protein binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
971 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CUTA | CUTC | Q9NTM9 | 736 |
| CUTA | HSPE1 | P61604 | 727 |
| CUTA | SYNGAP1 | Q96PV0 | 578 |
| CUTA | TAX1BP3 | O14907 | 547 |
| CUTA | BACE1 | P56817 | 507 |
| CUTA | HSPD1 | P10809 | 474 |
| CUTA | PHF1 | O43189 | 474 |
| CUTA | WASHC4 | Q2M389 | 435 |
| CUTA | GABRB1 | P18505 | 410 |
| CUTA | UBAC1 | Q9BSL1 | 410 |
| CUTA | WDR46 | O15213 | 405 |
| CUTA | PFDN6 | O15212 | 373 |
| CUTA | APEH | P13798 | 368 |
| CUTA | A0A1W2PPA2 | A0A1W2PPA2 | 368 |
| CUTA | NXN | Q6DKJ4 | 365 |
IntAct
22 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FBLIM1 | CUTA | psi-mi:“MI:0915”(physical association) | 0.740 |
| CUTA | FBLIM1 | psi-mi:“MI:0915”(physical association) | 0.740 |
| CUTA | PRKAG1 | psi-mi:“MI:0914”(association) | 0.530 |
| NR4A1 | CUTA | psi-mi:“MI:0915”(physical association) | 0.520 |
| CPLX3 | CUTA | psi-mi:“MI:0915”(physical association) | 0.400 |
| CUTA | MLH1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SOD1 | NPEPPSL1 | psi-mi:“MI:0914”(association) | 0.350 |
| CUTA | UBB | psi-mi:“MI:0914”(association) | 0.350 |
| FBLIM1 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| CUTA | ERI3 | psi-mi:“MI:0914”(association) | 0.350 |
| VHL | CUTA | psi-mi:“MI:0915”(physical association) | 0.000 |
| PINX1 | CUTA | psi-mi:“MI:0915”(physical association) | 0.000 |
| MCC | CUTA | psi-mi:“MI:0915”(physical association) | 0.000 |
| GRB2 | CUTA | psi-mi:“MI:0915”(physical association) | 0.000 |
| CUTA | NR4A1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| tolC | CUTA | psi-mi:“MI:0915”(physical association) | 0.000 |
| CUTA | psi-mi:“MI:0915”(physical association) | 0.000 | |
| CUTA | map | psi-mi:“MI:0915”(physical association) | 0.000 |
| aguA | CUTA | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (65): FBLIM1 (Two-hybrid), CUTA (Co-fractionation), PXDNL (Co-fractionation), CUTA (Affinity Capture-MS), CUTA (Affinity Capture-MS), UPP1 (Affinity Capture-MS), PRKAA1 (Affinity Capture-MS), CLTCL1 (Affinity Capture-MS), UBB (Affinity Capture-MS), PRKAB1 (Affinity Capture-MS), GID4 (Affinity Capture-MS), ARMC8 (Affinity Capture-MS), ZER1 (Affinity Capture-MS), PRKAG1 (Affinity Capture-MS), PDIA5 (Affinity Capture-MS)
ESM2 similar proteins: A0JPF9, A4D126, D2GU20, E1BCH6, E9PYK3, O35465, O60888, O75425, O75808, P43896, P47823, P69678, P97812, Q0VC80, Q13144, Q14318, Q27J81, Q2VPK5, Q3B7U9, Q3TX08, Q3U269, Q496Y0, Q499R4, Q5ND52, Q5RJG7, Q5S6T3, Q64350, Q66KY3, Q6MGD0, Q6ZT62, Q7T0X7, Q7T3C3, Q86U90, Q8BGG6, Q8BYH7, Q8CHW4, Q8HXH0, Q8IYL2, Q91YR5, Q96EN8
Diamond homologs: A4TRR5, A7FN06, A7ZV06, A8A7N3, A8AMR3, A9QYQ6, B1ITR1, B1JMR6, B1LQF8, B1XD17, B2K1X9, B2TY12, B4T2N5, B4TF74, B4TSC0, B5BKE7, B5F2K4, B5FRJ6, B5QZZ9, B5R985, B5Z2E7, B6I609, B7LBZ6, B7M8P8, B7MKU2, B7MSF8, B7NG75, B7NTJ6, C5A1C9, O28301, O58720, O60888, P69488, P69489, P69678, P93009, Q0SXE2, Q0T9Q4, Q109R6, Q1C0X5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
874 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:33416772:CAGAA:C | acceptor_gain | 1.0000 |
| 6:33417249:A:AC | donor_gain | 1.0000 |
| 6:33417250:C:CC | donor_gain | 1.0000 |
| 6:33417250:CATGG:C | donor_gain | 1.0000 |
| 6:33416773:AGAA:A | acceptor_gain | 0.9900 |
| 6:33416774:GAA:G | acceptor_gain | 0.9900 |
| 6:33416777:C:CC | acceptor_gain | 0.9900 |
| 6:33417091:TCTCA:T | donor_loss | 0.9900 |
| 6:33417093:TCA:T | donor_loss | 0.9900 |
| 6:33417096:C:CT | donor_loss | 0.9900 |
| 6:33417138:CATAG:C | acceptor_gain | 0.9900 |
| 6:33417140:TAG:T | acceptor_gain | 0.9900 |
| 6:33417143:C:CA | acceptor_loss | 0.9900 |
| 6:33417143:C:CC | acceptor_gain | 0.9900 |
| 6:33417244:GAC:G | donor_loss | 0.9900 |
| 6:33417245:ACT:A | donor_loss | 0.9900 |
| 6:33417246:CT:C | donor_loss | 0.9900 |
| 6:33417247:TCAC:T | donor_loss | 0.9900 |
| 6:33417248:CACAT:C | donor_loss | 0.9900 |
| 6:33417249:A:AG | donor_loss | 0.9900 |
| 6:33417250:C:T | donor_loss | 0.9900 |
| 6:33417250:CA:C | donor_gain | 0.9900 |
| 6:33417250:CATG:C | donor_gain | 0.9900 |
| 6:33417306:CGGCC:C | acceptor_gain | 0.9900 |
| 6:33417670:C:CT | acceptor_gain | 0.9900 |
| 6:33417670:C:T | acceptor_gain | 0.9900 |
| 6:33417671:A:T | acceptor_gain | 0.9900 |
| 6:33416775:AACTA:A | acceptor_loss | 0.9800 |
| 6:33416777:C:T | acceptor_loss | 0.9800 |
| 6:33416778:T:A | acceptor_loss | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1001093191 (6:33419095 G>C), RS1002716361 (6:33418485 G>T), RS1004492886 (6:33416085 G>A), RS1004624786 (6:33420017 C>CTCG), RS1006019701 (6:33418392 G>T), RS1007878051 (6:33417692 A>G), RS1009250484 (6:33418436 G>T), RS1010489520 (6:33417317 T>A), RS1010586011 (6:33418622 C>T), RS1010700519 (6:33418304 C>T), RS1011571867 (6:33416156 C>G,T), RS1011624341 (6:33416416 T>C), RS1012316140 (6:33417766 C>G,T), RS1013339851 (6:33419658 T>C,G), RS1013582120 (6:33416163 C>T)
Disease associations
OMIM: gene MIM:616953 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_251 | Autism spectrum disorder or schizophrenia | 6.000000e-12 |
| GCST004521_287 | Autism spectrum disorder or schizophrenia | 5.000000e-08 |
| GCST004521_75 | Autism spectrum disorder or schizophrenia | 8.000000e-10 |
| GCST005951_153 | Body mass index | 5.000000e-09 |
| GCST007656_5 | Chronic obstructive pulmonary disease or resting heart rate (pleiotropy) | 3.000000e-15 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067022 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, decreases expression, decreases methylation, increases expression | 4 |
| (+)-JQ1 compound | decreases expression | 3 |
| Arsenic | affects methylation, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| isobutyl alcohol | affects cotreatment, decreases expression, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| K 7174 | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| bisphenol S | increases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Aminoglutethimide | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Dimethyl Sulfoxide | affects expression | 1 |
| Doxorubicin | affects expression | 1 |
| Gasoline | increases abundance, affects cotreatment, decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Polycyclic Aromatic Hydrocarbons | decreases expression, increases abundance, affects cotreatment | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Tretinoin | decreases expression | 1 |
| Zearalenone | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Genistein | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651226 | Binding | Binding affinity to human CUTA incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.